发明名称 PHARMACEUTICAL FORMULATIONS OF RESVERATROL AND METHODS OF USE THEREOF FOR TREATING CELL DISORDERS
摘要 A method of inducing NAD+ synthesis in a subject. The method comprises administering to the subject a therapeutically effective amount of resveratrol or a functionally equivalent analogue or derivative thereof. NAD+ synthesis increases the activity of Poly(ADP-ribose) polymerase (PARP) enzymes and sirtuin enzymes. The PARP enzyme is PARP-1 or PARP-2 and the sirtuin enzyme is selected from the group consisting of SIRT1, SIRT2, SIRT3, SIRT4, SIRT5, SIRT6 and SIRT7.
申请公布号 US2011110913(A1) 申请公布日期 2011.05.12
申请号 US20090735931 申请日期 2009.03.03
申请人 发明人 GRANT ROSS STEWART;BRAIDY NADY;GUILLEMIN GILLES;SMYTHE GEORGE
分类号 A61K38/44;A61K31/05;A61K31/07;A61K31/185;A61K31/198;A61K31/355;A61K31/375;A61K31/4045;A61P25/00;A61P25/16;A61P25/28;A61P35/00;A61P39/04;A61P39/06;C07C39/21 主分类号 A61K38/44
代理机构 代理人
主权项
地址